These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21788546)

  • 1. New anticoagulant drugs among elderly patients is caution necessary?: Comment on "The use of dabigatran in elderly patients".
    Jacobs JM; Stessman J
    Arch Intern Med; 2011 Jul; 171(14):1287-8. PubMed ID: 21788546
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of dabigatran in elderly patients.
    Legrand M; Mateo J; Aribaud A; Ginisty S; Eftekhari P; Huy PT; Drouet L; Payen D
    Arch Intern Med; 2011 Jul; 171(14):1285-6. PubMed ID: 21788545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: NICE guidance.
    Ahmad Y; Lip GY
    Heart; 2012 Oct; 98(19):1404-6. PubMed ID: 22698856
    [No Abstract]   [Full Text] [Related]  

  • 4. Dabigatran in clinical practice.
    Nagarakanti R; Ellis CR
    Clin Ther; 2012 Oct; 34(10):2051-60. PubMed ID: 23031622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy).
    Reilly PA; Lehr T; Haertter S; Connolly SJ; Yusuf S; Eikelboom JW; Ezekowitz MD; Nehmiz G; Wang S; Wallentin L;
    J Am Coll Cardiol; 2014 Feb; 63(4):321-8. PubMed ID: 24076487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bleeding with dabigatran (Pradaxa).
    Med Lett Drugs Ther; 2011 Dec; 53(1379-1380):98. PubMed ID: 22173427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation.
    Lip GY; Larsen TB; Skjøth F; Rasmussen LH
    J Am Coll Cardiol; 2012 Aug; 60(8):738-46. PubMed ID: 22575324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bleeding events and activated partial thromboplastin time with dabigatran in clinical practice.
    Kawabata M; Yokoyama Y; Sasano T; Hachiya H; Tanaka Y; Yagishita A; Sugiyama K; Nakamura T; Suzuki M; Isobe M; Hirao K
    J Cardiol; 2013 Aug; 62(2):121-6. PubMed ID: 23680005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dabigatran etexilate: future directions in anticoagulant treatment.
    Schulman S; Reilly PA
    Clin Appl Thromb Hemost; 2009; 15 Suppl 1():32S-41S. PubMed ID: 19679590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: resolving uncertainties in routine practice.
    Huisman MV; Lip GY; Diener HC; Brueckmann M; van Ryn J; Clemens A
    Thromb Haemost; 2012 May; 107(5):838-47. PubMed ID: 22318514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboembolic prophylaxis in orthopedic surgery using dabigatran: an oral direct thrombin inhibitor.
    Garza R; Huo MH
    Expert Rev Cardiovasc Ther; 2012 Apr; 10(4):423-7. PubMed ID: 22458575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of anticoagulation control in atrial fibrillation.
    Lane DA; Lip GY
    Lancet; 2010 Sep; 376(9745):935-7. PubMed ID: 20801499
    [No Abstract]   [Full Text] [Related]  

  • 13. Dabigatran and factor Xa inhibitors for stroke prevention in patients with nonvalvular atrial fibrillation.
    Uchiyama S; Ibayashi S; Matsumoto M; Nagao T; Nagata K; Nakagawara J; Tanahashi N; Tanaka K; Toyoda K; Yasaka M
    J Stroke Cerebrovasc Dis; 2012 Apr; 21(3):165-73. PubMed ID: 22440950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dabigatran: safer, more effective and easier to use than warfarin.
    Cardiovasc J Afr; 2009; 20(5):311-2. PubMed ID: 19907807
    [No Abstract]   [Full Text] [Related]  

  • 15. NICE backs new oral anticoagulant for stroke prevention.
    Wise J
    BMJ; 2012 Mar; 344():e2111. PubMed ID: 22427274
    [No Abstract]   [Full Text] [Related]  

  • 16. Namibia becomes first country in Africa to launch dabigatran etexilate for atrial fibrillation.
    Wagenaar P
    Cardiovasc J Afr; 2011; 22(5):283. PubMed ID: 21983957
    [No Abstract]   [Full Text] [Related]  

  • 17. Dabigatran versus warfarin for patients with non-valvular atrial fibrillation: is the patient the winner?
    Grave S
    Aust Nurs J; 2011 Dec-2012 Jan; 19(6):30-3. PubMed ID: 22329103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rectal bleeding and hemostatic disorders induced by dabigatran etexilate in 2 elderly patients.
    Béné J; Saïd W; Rannou M; Deheul S; Coupe P; Gautier S
    Ann Pharmacother; 2012 Jun; 46(6):e14. PubMed ID: 22669799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dabigatran: will it change clinical practice?
    Wartak SA; Bartholomew JR
    Cleve Clin J Med; 2011 Oct; 78(10):657-64. PubMed ID: 21968472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stroke prophylaxis with warfarin or dabigatran for patients with non-valvular atrial fibrillation-cost analysis.
    Ali A; Bailey C; Abdelhafiz AH
    Age Ageing; 2012 Sep; 41(5):681-4. PubMed ID: 22378612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.